PLK4 and cancer: Numerous studies have demonstrated the vital oncogenic role of AURKB (30), BIRC5 (31), KIF11 (32), PLK1 (33), PLK4 (34), RAD51 (35), TOP2A (36), TTK (37), and TUBB3 (38) in various cancers, including HCC.